UPSC DAW Mains Answer Writing 24th July 2025

UPSC DAW Mains Answer Writing 24th July 2025

Question

Scientific advancements have provided alternatives to animal testing through the development of bioartificial models and tissue-engineered anatomical parts. In this context, discuss the ethical concerns associated with animal experimentation in laboratories. How can administrators and policymakers reconcile the need for scientific progress with compassion for animal life? (10 marks, 150 words) 

Model Answer

Introduction:  

  • The ethical treatment of animals in scientific research presents a moral dilemma between human advancement and animal suffering. While the pursuit of scientific knowledge has historically justified animal experimentation, ethical theories like utilitarianism and rights-based ethics challenge such practices today. With advances in biotechnology, especially in tissue engineering and regenerative medicine, the possibility of replacing animal testing with lab-grown biological models has introduced a critical shift in how we perceive and practice scientific research ethically. 

 Ethical Concerns Associated with Animal Experimentation: 

  • Violation of Animal Rights: 

  • According to rights-based ethics (Tom Regan), animals possess intrinsic value and are not merely instruments for human use. Testing causes pain, confinement, and early death, violating their dignity. 

  • Utilitarian Critique: 

  • Jeremy Bentham famously asked, ‘The question is not, can they reason? nor, can they talk? but, can they suffer?’ The moral cost of inflicting suffering outweighs the uncertain benefit to humans. 

  • Lack of Predictive Validity: 

  • A 2022 review in Nature Reviews Drug Discovery notes that over 90% of drugs that pass animal testing fail in human trials, questioning the scientific merit of the practice. 

  • Moral Precedent: 

  • As highlighted in historical studies such as the U.S. ‘Poison Squad’ experiment (1902–1904), the rationalization of testing can be redirected toward vulnerable human populations if ethical boundaries are not upheld. 

  • Desensitisation of Scientific Temper: 

  • Regular exposure to animal suffering may lead to moral numbness among researchers, normalizing cruelty. This contradicts the Gandhian ethic of ahimsa and erodes the ethical sensibility of future medical and scientific professionals. 

 Reconciliation: Scientific Progress and Compassion: 

  • Promotion of Bioartificial and Ex-Corpus Models: 

  • India has growing tissue engineering capabilities. Institutions like CSIR-IGIB and IITs are developing organoids and organ-on-chip models (E.g., liver and heart tissues for drug toxicity testing). These can be scaled under NITI Aayog’s Atal Innovation Mission. 

  • Legislative Reform: 

  • The Prevention of Cruelty to Animals Act, 1960, particularly Chapter IV, could be amended to mandate the use of alternatives ‘wherever possible.’ Similar shifts have occurred under EU Directive 2010/63/EU, which promotes the 3Rs principle – Replacement, Reduction, Refinement. 

  • Judicial Standpoint: 

  • In Animal Welfare Board of India v. A. Nagaraja (2014), the Supreme Court recognised Article 21 protection for animals under the expanded right to life and dignity, strengthening the moral claim for humane research methods. 

  • Curriculum and Pedagogy Shift: 

  • CBSE and UGC have largely phased out animal dissections, replacing them with virtual dissection software and 3D anatomical simulations, demonstrating scalable, compassionate alternatives in education. 

  • Dedicated Regulatory and Ethical Oversight Mechanism: 

  • A specialised cell under CPCSEA (Committee for the Purpose of Control and Supervision of Experiments on Animals) can be empowered to oversee the adoption of non-animal methods and enforce periodic audits. This promotes both scientific accountability and ethical responsibility. 

 Way Forward:  

  • Institutional Incentives: Provide grants, tax benefits, and regulatory fast-tracking for labs using non-animal models. 

  • Coordination with Biotech Startups: Leverage Startup India ecosystem to develop cost-effective bioartificial models. 

  • Awareness Campaigns: Public campaigns can reduce demand for products tested on animals and raise support for cruelty-free practices. 

  • Data-Sharing and Collaboration: Create open-access databases for tissue testing results to build a knowledge repository across labs and institutions. 

 Conclusion:  

  • True scientific progress lies not just in discovering new drugs, but in evolving our moral conscience. By shifting from animal models to humane, lab-grown alternatives, we uphold the ethics of compassion, sustainability, and scientific integrity. Governance and administration must enable this shift through legislation, innovation, and public awareness, recognizing that the dignity of life, human or animal, must be at the core of our progress.